References
- Adinolfi L E, Gambardella M, Andreana A.et al Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001331358–1364.
- Clark J M, Brancati F L, Diehl A M. Nonalcoholic fatty liver disease. Gastroenterology 20021221649–1657.
- Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357(9262):1069–75.
- Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1Suppl):S47–64.
- Bochud PY, Cai T, Overbeck K, et al. Genotype 3 is associated with 2009;51(4):655–66.
- Kralj D, Virovic Jukic L, Stojsavljevic S, et al. Hepatitis C Virus, Insulin Resistance, and Steatosis. J Clin Translational Hepatol. 2016;4(1):66–75.
- Seronello S, Ito C, Wakita T, Choi J. Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+. J Biol Chem. 2010;285(2): 845–54.
- Del Campo JA, Romero-Gomez M. Steatosis and insulin resistance in hepatitis C: a way out for the virus? World J Gastroenterol. 2009;15(40):5014–9.
- Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000;33(1):106–15.
- Chitturi S, Farrell G C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 20012127–41.
- Rubbia-Brandt L, Giostra E, Mentha G, Quadri R, Negro F. Expression of liver steatosis in hepatitis C virus infection and pattern of response to alphainterferon. J Hepatol. 2001;35(2):307.
- Bochud PY, Cai T, Overbeck K, et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol. 2009;51(4):655–66.
- Sanyal A J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 20021231705–1725
- Meissner EG, Lee YJ, Osinusi A, et al. Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients. Hepatology (Baltimore, Md). 2015;61(3):790–801.
- Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010;42:503–508.